Rocket Pharmaceuticals (RCKT) PT Raised to $15 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts RCKT Hot Sheet
Price: $3.34 --0%
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 10
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 10
Join SI Premium – FREE
Cantor Fitzgerald analyst Josh Schimmer raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $15.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- Bending Spoons (BSP) PT Raised to $47 at Bernstein SocGen Group
- Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
